ArticleDrug and alcohol dependence2019
Appeal of JUUL among adolescents.
Article in Drug and alcohol dependence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Youth use of e-liquid flavours-a systematic review exploring patterns of use of e-liquid flavours and associations with continued vaping, tobacco smoking uptake or cessation.Addiction (Abingdon, England) · 2022Pooled it
- E-cigarette device type and combustible tobacco use: Results from a pooled analysis of 10,482 youth.Drug and alcohol dependence · 2022Pooled it
- Effects of tobacco product type and characteristics on appeal and perceived harm: Results from a discrete choice experiment among Guatemalan adolescents.Preventive medicine · 2021Trial
- Trial
- Prevalence, perceived effects, and motivations for adolescent e-cigarette use: A cross-sectional study in the Paris region.Tobacco prevention & cessation · 2026Article
- Electronic cigarettes: isolated and combined use among Brazilian adolescents in PeNSE 2019.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2026Article
- COVID-19 Disease and Chronic Health Outcomes Associated with Nicotine Use in a Great Plains Tribal Community: A Community-Based Study.Journal of racial and ethnic health disparities · 2025Article
- Use of cannabis among youth who vape nicotine.Addictive behaviors · 2025Article
- California School Staff Reports of Seeing Students Vaping at School and Disciplinary Actions.The Journal of school nursing : the official publication of the National Association of School Nurses · 2024Article
- The e-cigarette assessment for youth-Revised (EAsY-R): Preliminary results of a pilot study of measure refinement via cognitive interviewing.Journal of research on adolescence : the official journal of the Society for Research on Adolescence · 2024Article
- Sex differences in appeal, reward, and sensory experience of E-cigarette flavors among adults who smoke cigarettes.Preventive medicine · 2024Article
- Public Perceptions and Discussions of the US Food and Drug Administration's JUUL Ban Policy on Twitter: Observational Study.JMIR formative research · 2024Article
- Assessing the public discourse on Twitter: Reactions to the JUUL e-cigarettes ban in the United States.Tobacco induced diseases · 2024Article
- Flavors increase adolescents' willingness to try nicotine and cannabis vape products.Drug and alcohol dependence · 2023Article
- Article
- The association of amygdala-insula functional connectivity and adolescent e-cigarette use via sleep problems and depressive symptoms.Addictive behaviors · 2022Article
- Electronic Cigarettes: A Pro-Con Review of the Current Literature.The journal of allergy and clinical immunology. In practice · 2022Review
- Disposable Puff Bar Electronic Cigarettes: Chemical Composition and Toxicity of E-liquids and a Synthetic Coolant.Chemical research in toxicology · 2022Article
- Alexithymia mediates the association between childhood trauma and adolescent E-cigarette use.Drug and alcohol dependence · 2022Article
- E-cigarette devices, brands, and flavors attract youth: Informing FDA's policies and priorities to close critical gaps.Addictive behaviors · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionJUUL is a closed-system e-cigarette that uses disposable pods with high concentrations of nicotine. JUUL use among youth arose exponentially since 2015, thus, it is essential to understand youths' reasons for liking/disliking JUUL to inform the regulation of the product.
methodsA cross-sectional survey was conducted in 4 high schools in Connecticut in 2018 (N = 3170). The survey assessed JUUL use in the past month and reasons for liking/disliking JUUL, which included pharmacological effects (e.g., subjective nicotine and/or flavor effects), product characteristics (e.g., flavors, nicotine, shape), peer influence (e.g., friends' use), comparisons to other e-cigarettes (e.g., lower harm), and concealability (e.g., hide from authority).
results30.2% (N = 956) were past-month users who used a JUUL on an average of 13.6 days (SD = 11.7; 25% reported daily use). The top reasons for liking JUUL were: "it gives me a buzz" (52%), "I like the flavors" (43%), and "my friends use it" (36%). The top reasons for disliking JUUL were: "the pods are expensive" (57%), "nicotine is too high" (20%), and "it gives me a headache" (18%). Regression models indicated that liking JUUL because of the buzz, ability to help concentrate, nicotine level, and ease of hiding it from teachers were associated with more days of use in the past month, while peer influence was negatively associated. Furthermore, disliking the high cost of pods was associated with more frequent use.
conclusionsComprehensive policies that regulate device characteristics that appeal to youth (e.g., nicotine level, flavors) are needed to prevent JUUL use among youth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.